Sellas Life Sciences Stock Working Capital

SLS Stock

USD 1.26 0.01 0.80%

Sellas Life Sciences fundamentals help investors to digest information that contributes to Sellas Life's financial success or failures. It also enables traders to predict the movement of Sellas Stock. The fundamental analysis module provides a way to measure Sellas Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sellas Life stock.

	Last Reported	Projected for Next Year
Net Working Capital	-10.6 M	-10 M
Change In Working Capital	3.3 M	3.5 M

Change In Working Capital is likely to gain to about 3.5 M in 2024, despite the fact that Net Working Capital is likely to grow to (10 M).

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sellas Life Sciences Company Working Capital Analysis

Sellas Life's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current Sellas Life Working Capital

(10.56 M)

Most of Sellas Life's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sellas Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Sellas Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for Sellas Life is extremely important. It helps to project a fair market value of Sellas Stock properly, considering its historical fundamentals such as Working Capital. Since Sellas Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sellas Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sellas Life's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Total Current Assets	Retained Earnings	Accounts Payable	Total Liab	Common Stock	Current Deferred Revenue	Short Term Debt	Net Tangible Assets	Good Will	Long Term Debt Total	Capital Surpluse	Intangible Assets	Property Plant Equipment	Long Term Debt	Deferred Long Term Liab	Net Receivables	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.66	-0.6	0.92	-0.5	-0.17	0.86	0.81	0.65	0.45	0.05	0.61	0.64	0.73	0.78	-0.31	0.6	0.44	0.46	-0.05	0.48	-0.2	-0.29
Total Stockholder Equity	0.66		-0.49	0.6	-0.23	-0.26	0.19	0.49	0.26	0.32	0.71	0.39	0.09	0.55	0.51	-0.36	0.02	0.15	0.06	-0.05	0.7	0.25	-0.31
Net Debt	-0.6	-0.49		-0.76	0.15	0.28	-0.45	-0.28	-0.29	0.31	-0.28	-0.26	-0.24	-0.28	-0.16	-0.16	-0.23	-0.2	-0.33	0.34	-0.51	-0.34	0.3
Total Current Assets	0.92	0.6	-0.76		-0.5	-0.21	0.79	0.7	0.6	0.34	0.08	0.48	0.61	0.7	0.52	-0.13	0.61	0.46	0.53	0.05	0.55	0.02	-0.35
Retained Earnings	-0.5	-0.23	0.15	-0.5		0.29	-0.54	-0.73	-0.54	-0.49	-0.12	-0.2	-0.74	-0.88	-0.34	-0.27	-0.77	-0.06	-0.34	-0.62	0.23	0.18	0.05
Accounts Payable	-0.17	-0.26	0.28	-0.21	0.29		-0.07	-0.42	-0.18	0.06	-0.42	-0.56	-0.11	-0.47	-0.17	-0.13	-0.17	-0.38	-0.28	0.03	-0.11	0.03	0.07
Total Liab	0.86	0.19	-0.45	0.79	-0.54	-0.07		0.75	0.67	0.37	-0.38	0.54	0.79	0.61	0.68	-0.12	0.8	0.46	0.55	0.0	0.12	-0.43	-0.2
Common Stock	0.81	0.49	-0.28	0.7	-0.73	-0.42	0.75		0.67	0.58	0.1	0.72	0.62	0.88	0.71	-0.33	0.67	0.54	0.53	0.23	0.09	-0.47	0.0
Current Deferred Revenue	0.65	0.26	-0.29	0.6	-0.54	-0.18	0.67	0.67		0.23	-0.11	0.33	0.58	0.65	0.55	-0.17	0.8	0.18	0.82	0.16	0.15	-0.17	-0.05
Short Term Debt	0.45	0.32	0.31	0.34	-0.49	0.06	0.37	0.58	0.23		-0.11	0.3	0.47	0.62	0.46	-0.42	0.38	0.37	0.05	0.61	0.15	-0.34	-0.12
Net Tangible Assets	0.05	0.71	-0.28	0.08	-0.12	-0.42	-0.38	0.1	-0.11	-0.11		0.1	-0.31	0.26	-0.01	0.04	-0.31	-0.18	-0.16	-0.01	0.3	0.41	-0.15
Good Will	0.61	0.39	-0.26	0.48	-0.2	-0.56	0.54	0.72	0.33	0.3	0.1		0.16	0.49	0.68	-0.39	0.22	0.82	0.45	-0.3	0.24	-0.62	-0.24
Long Term Debt Total	0.64	0.09	-0.24	0.61	-0.74	-0.11	0.79	0.62	0.58	0.47	-0.31	0.16		0.7	0.5	0.16	0.9	0.07	0.26	0.39	-0.04	-0.13	-0.04
Capital Surpluse	0.73	0.55	-0.28	0.7	-0.88	-0.47	0.61	0.88	0.65	0.62	0.26	0.49	0.7		0.58	-0.04	0.72	0.31	0.44	0.47	0.16	-0.17	-0.16
Intangible Assets	0.78	0.51	-0.16	0.52	-0.34	-0.17	0.68	0.71	0.55	0.46	-0.01	0.68	0.5	0.58		-0.41	0.41	0.32	0.25	-0.24	0.26	-0.49	-0.2
Property Plant Equipment	-0.31	-0.36	-0.16	-0.13	-0.27	-0.13	-0.12	-0.33	-0.17	-0.42	0.04	-0.39	0.16	-0.04	-0.41		0.14	-0.43	-0.13	0.14	-0.31	0.37	-0.16
Long Term Debt	0.6	0.02	-0.23	0.61	-0.77	-0.17	0.8	0.67	0.8	0.38	-0.31	0.22	0.9	0.72	0.41	0.14		0.16	0.61	0.44	-0.09	-0.19	-0.07
Deferred Long Term Liab	0.44	0.15	-0.2	0.46	-0.06	-0.38	0.46	0.54	0.18	0.37	-0.18	0.82	0.07	0.31	0.32	-0.43	0.16		0.49	-0.1	0.27	-0.54	-0.21
Net Receivables	0.46	0.06	-0.33	0.53	-0.34	-0.28	0.55	0.53	0.82	0.05	-0.16	0.45	0.26	0.44	0.25	-0.13	0.61	0.49		0.04	0.14	-0.25	-0.13
Short Long Term Debt	-0.05	-0.05	0.34	0.05	-0.62	0.03	0.0	0.23	0.16	0.61	-0.01	-0.3	0.39	0.47	-0.24	0.14	0.44	-0.1	0.04		-0.22	0.11	0.07
Net Invested Capital	0.48	0.7	-0.51	0.55	0.23	-0.11	0.12	0.09	0.15	0.15	0.3	0.24	-0.04	0.16	0.26	-0.31	-0.09	0.27	0.14	-0.22		0.46	-0.43
Net Working Capital	-0.2	0.25	-0.34	0.02	0.18	0.03	-0.43	-0.47	-0.17	-0.34	0.41	-0.62	-0.13	-0.17	-0.49	0.37	-0.19	-0.54	-0.25	0.11	0.46		-0.09
Capital Stock	-0.29	-0.31	0.3	-0.35	0.05	0.07	-0.2	0.0	-0.05	-0.12	-0.15	-0.24	-0.04	-0.16	-0.2	-0.16	-0.07	-0.21	-0.13	0.07	-0.43	-0.09

Click cells to compare fundamentals

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Competition

Predict Sellas Life

Working Capital Over Time

Sellas Capital Surpluse

Capital Surpluse

134.95 Million

At this time, Sellas Life's Capital Surpluse is comparatively stable compared to the past year.

Based on the company's disclosures, Sellas Life Sciences has a Working Capital of (10.56 Million). This is 102.48% lower than that of the Biotechnology sector and 101.96% lower than that of the Health Care industry. The working capital for all United States stocks is 100.71% higher than that of the company.

Sellas Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sellas Life's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sellas Life could also be used in its relative valuation, which is a method of valuing Sellas Life by comparing valuation metrics of similar companies.

Sellas Life is currently under evaluation in working capital category among its peers.

Sellas Fundamentals

	Return On Equity	-8.88
	Return On Asset	-1.29
	Current Valuation	72.6 M
	Shares Outstanding	64.33 M
	Shares Owned By Insiders	0.24 %
	Shares Owned By Institutions	9.50 %
	Number Of Shares Shorted	8.18 M
	Price To Book	27.83 X
	Price To Sales	26.90 X
	Gross Profit	900 K
	EBITDA	529 K
	Net Income	(37.34 M)
	Cash And Equivalents	26.99 M
	Cash Per Share	1.31 X
	Total Debt	906 K
	Debt To Equity	0.06 %
	Current Ratio	2.36 X
	Book Value Per Share	0.05 X
	Cash Flow From Operations	(31.41 M)
	Short Ratio	17.25 X
	Earnings Per Share	(0.90) X
	Target Price	5.83
	Number Of Employees	16
	Beta	2.39
	Market Capitalization	81.06 M
	Total Asset	6.4 M
	Retained Earnings	(217.24 M)
	Working Capital	(10.56 M)
	Net Asset	6.4 M

About Sellas Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sellas Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sellas Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sellas Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC